Edity Therapeutics
Using human immune cells to deliver therapeutic proteins
Israel
22 employees
Seed
Biotechnology, Health and Wellness +1
General Information
Israel
BounceWatch is an independent company data service, not affiliated with Edity Therapeutics . To contact Edity Therapeutics , visit edity-tx.com.
Is this your company?
Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.
Get Verified
How does Edity Therapeutics compare?
A PDF of Edity Therapeutics and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.
This takes a few seconds: we look beyond our own index too.
Meeting Edity Therapeutics soon?
A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample
Discover More
Israel Market
Biotechnology
About Edity Therapeutics
Business keywords: gene editing, cell therapy, immune cells, therapeutic proteins, drug delivery, in-vivo gene editing, T-cells, cancer, intracellular pathways, target cells, enzyme therapy, immunotherapy, innovation, startup
Funding Rounds & Investors (3)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Seed Round | Undisclosed | 2 |
|
12 Jul 2022 |
| Seed Round | Undisclosed | 1 |
|
01 Mar 2021 |
| Pre Seed Round | Undisclosed | 1 |
Roy Oron
|
01 Jan 2020 |
Edity Therapeutics Alternatives & Competitors
View All Alternatives
Cell therapy company dedicated to improving the lives of patients with rare diseases
Delivering intracellular therapeutics with ARMMed microvesicles
SPEARHEADING IMMUNOTHERAPIES
FAQ About Edity Therapeutics
Source: BounceWatch company record for Edity Therapeutics , https://bouncewatch.com/company/edity-therapeutics, updated 30 December 2024. When citing, please name BounceWatch and link this page.
